Size | Price | Stock | Qty |
---|---|---|---|
1mg |
|
||
Other Sizes |
|
Targets |
Natural flavonoid from green tea
|
---|---|
ln Vitro |
Antioxidative activity of (-)-epigallocatechin-3-(3''-O-methyl)gallate (catechin e) was examined. Catechin e showed a strong antioxidative activity. A preliminary test using rat cancer cells suggests that catechin e also has a strong cytotoxic activity. Among tested catechins, only catechin e has strong activity for both[1].
|
Enzyme Assay |
DPPH Assay[2]
DPPH decolorimetric assay was performed to examine the scavenging effect of 3″Me-EGCG as previously described. 3″Me-EGCG (0–12.5 μM) was mixed with 250 mM DPPH and incubated at 37 °C for 30 min. Ascorbic acid (500 μM) was used as a positive control. After incubation, the absorbance at 517 nm was measured by spectrophotometry. DPPH scavenging effect was expressed as percent inhibition as follows: DPPH scavenging effect (%) = [(A0 − A1)/A0] ∗ 100 (1) in which A0 indicates the absorbance of DPPH, and A1 is the absorbance of samples. ABTS Assay[2] ABTS scavenging assay was conducted as previously described with little modification. A mixture of 7.4 mM ABTS and 2.4 mM potassium persulfate at a 1:1 ratio was incubated overnight at room temperature to generate ABTS radical cation (ABTS•+). ABTS solution and 3″Me-EGCG (0–12.5 μM) were mixed at a 1:1 ratio in a 96-well plate. Ascorbic acid (50 μM) was used as a positive control. After 30 min of incubation at 37°C, the absorbance of each fraction was measured at 730 nm. ABTS scavenging effect was expressed as a percentage as follows: ABTS scavenging effect (%) = [(A0 − A1)/A0] ∗ 100 (2) in which A0 indicates the absorbance of ABTS, and A1 is the absorbance of samples. ROS Generation[2] The intracellular ROS level was determined by changes of fluorescence resulting from oxidation of the DHR123 fluorescent probe. Briefly, 1 × 106 RAW264.7 cells were incubated with 3″Me-EGCG for 30 min, and then SNP (0.25 mM) was added to induce ROS production. The cells were further incubated with 20 μM of the fluorescent probe DHR123 for 30 min at 37 °C, and cells were washed with PBS. The degree of fluorescence, which corresponds to the level of intracellular ROS, was determined using a FACScan flow cytometer (Becton-Dickinson, San Jose, CA, USA) as reported previously |
Cell Assay |
Cell Viability Test[2]
The cytotoxicity of 3″Me-EGCG in RAW264.7 and HaCaT cells was evaluated as previously reported [6]. RAW264.7 cells (1 × 106 cells/mL) and HaCaT cells (4 × 106 cells/mL) were plated and cultured overnight, and 3″Me-EGCG (0–12.5 μM) was added for 24 h. Cell culture media (100 μL) were removed, and 10 μL MTT solution was added to each well. After 3 h of formazan formation, formazan dissolving solution was added. The absorbance at 570 nm was measured. UVB Irradiation[2] HaCaT cells were seeded at 7 × 105 cells per well in six-well plates and incubated for 24 h under starvation conditions using serum-free MEM. The media were changed to DMEM with 10% FBS and 1% penicillin-streptomycin, and cells were pre-treated with 3″Me-EGCG (0–12.5 μM) for 30 min. Cells were washed with DPBS to remove media, and 1 mL media was added to each well. Cells were irradiated with 30 mJ/cm2 UVB (UVB lamp, Bio-link crosslinker BLX-312; Vilber Lourmat, Collegien, France). Media was removed, and DMEM media with 3″Me-EGCG (0–12.5 μM) was added to cells; cells were incubated for 48 h. Reactive oxygen species (ROS) are generated from diverse cellular processes or external sources such as chemicals, pollutants, or ultraviolet (UV) irradiation. Accumulation of radicals causes cell damage that can result in degenerative diseases. Antioxidants remove radicals by eliminating unpaired electrons from other molecules. In skin health, antioxidants are essential to protect cells from the environment and prevent skin aging. (-)-Epigallocatechin-3-(3″-O-methyl) gallate (3″Me-EGCG) has been found in limited oolong teas or green teas with distinctive methylated form, but its precise activities have not been fully elucidated. In this study, we examined the antioxidant roles of 3″Me-EGCG in keratinocytes (HaCaT cells). 3″Me-EGCG showed scavenging effects in cell and cell-free systems. Under H2O2 exposure, 3″Me-EGCG recovered cell viability and increased the expression of heme oxygenase 1 (HO-1). Under ultraviolet B (UVB) and sodium nitroprusside (SNP) exposure, 3″Me-EGCG protected keratinocytes and regulated the survival protein AKT1. By regulating the AKT1/NF-κB pathway, 3″Me-EGCG augmented cell survival and proliferation in HaCaT cells. These results indicate that 3″Me-EGCG exhibits antioxidant properties, resulting in cytoprotection against various external stimuli. In conclusion, our findings suggest that 3″Me-EGCG can be used as an ingredient of cosmetic products or health supplements[2]. |
References |
|
Additional Infomation |
(-)-Epigallocatechin 3-(3-methyl-gallate) is a catechin.
Epigallocatechin 3-O-(3-O-methyl)gallate has been reported in Limonium sinense with data available. |
Molecular Formula |
C₂₃H₂₀O₁₁
|
---|---|
Molecular Weight |
472.40
|
Exact Mass |
472.1
|
CAS # |
83104-87-4
|
PubChem CID |
9804842
|
Appearance |
Off-white to pink solid powder
|
Density |
1.77
|
Boiling Point |
856.1±65.0 °C at 760 mmHg
|
Melting Point |
221-223 ºC(dec.)
|
Flash Point |
298.9±27.8 °C
|
Vapour Pressure |
0.0±0.3 mmHg at 25°C
|
Index of Refraction |
1.796
|
LogP |
2.03
|
Hydrogen Bond Donor Count |
7
|
Hydrogen Bond Acceptor Count |
11
|
Rotatable Bond Count |
5
|
Heavy Atom Count |
34
|
Complexity |
694
|
Defined Atom Stereocenter Count |
2
|
SMILES |
COC1=CC(=CC(=C1O)O)C(=O)O[C@@H]2CC3=C(C=C(C=C3O[C@@H]2C4=CC(=C(C(=C4)O)O)O)O)O
|
InChi Key |
WVRDOLPMKOCJRJ-DENIHFKCSA-N
|
InChi Code |
InChI=1S/C23H20O11/c1-32-18-5-10(4-16(28)21(18)30)23(31)34-19-8-12-13(25)6-11(24)7-17(12)33-22(19)9-2-14(26)20(29)15(27)3-9/h2-7,19,22,24-30H,8H2,1H3/t19-,22-/m1/s1
|
Chemical Name |
[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4-dihydroxy-5-methoxybenzoate
|
Synonyms |
83104-87-4; (-)-EGCG-3''-O-Me; Epigallocatechin 3-O-(3-O-methyl)gallate; (-)-Epigallocatechin-3-(3''-O-methyl) gallate; Egcg3''me; O97U9TPY8V; Epigallocatechin 3-O-(3-O-methylgallate); CHEMBL562716;
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
---|---|
Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.1169 mL | 10.5843 mL | 21.1685 mL | |
5 mM | 0.4234 mL | 2.1169 mL | 4.2337 mL | |
10 mM | 0.2117 mL | 1.0584 mL | 2.1169 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.